Clozaril
In brief
- Clozaril (clozapine) is a prescription-only medicine in the UK; it is supplied via authorised pharmacies and specialist services under a controlled distribution and monitoring programme and cannot be legally dispensed without a valid prescription and enrolment in the blood-monitoring programme—if a pharmacy offers it without a prescription this is not legal or safe.
- Clozapine is used for treatment-resistant schizophrenia and psychotic disorders in Parkinson's disease; it is an atypical (second‑generation) antipsychotic that acts mainly by antagonising serotonin 5‑HT2A receptors and dopaminergic D2 receptors (with additional effects at multiple neurotransmitter systems), producing antipsychotic and mood‑stabilising effects.
- Usual adult dosing starts at 12.5 mg once or twice on day 1 with gradual titration to an effective range of about 300–450 mg/day in divided doses over 2–3 weeks (maximum reported doses up to 900 mg/day); elderly and those with hepatic/renal impairment require lower starting doses and slower titration.
- Forms of administration include immediate‑release tablets (25 mg, 50 mg, 100 mg, 200 mg), orally disintegrating tablets (12.5 mg, 25 mg, 100 mg) and an oral suspension (50 mg/mL).
- Initial sedative effects and some symptomatic changes can occur within hours to days, but meaningful antipsychotic benefit commonly takes 1–4 weeks to emerge and several weeks for full effect.
- The clinical effect is maintained with regular daily dosing; pharmacokinetic half‑life is typically about 8–12 hours (variable), so dosing is usually once or twice daily and therapeutic coverage is continuous with adherence—treatment is generally long‑term for maintenance.
- Do not consume alcohol while taking clozapine; alcohol markedly increases sedation, orthostatic hypotension and respiratory depression and may increase seizure risk when combined with clozapine.
- The most common side effect is drowsiness/sedation; other frequent adverse effects include sialorrhoea (excess saliva), tachycardia, orthostatic hypotension, constipation, weight gain and tremor—serious risks include agranulocytosis, seizures and myocarditis, so mandatory regular blood monitoring is required.
- Would you like to try Clozaril without a prescription?
Basic Clozaril information
- INN (international nonproprietary name): Clozapine.
- Brand names available in the United Kingdom: Clozaril; generic clozapine.
- ATC code: N05AH02.
- Forms and dosages: Tablets 25 mg, 50 mg, 100 mg, 200 mg; Orally disintegrating tablets (ODT) 12.5 mg, 25 mg, 100 mg; Oral suspension 50 mg/mL.
- Manufacturers in the United Kingdom: Sandoz (Novartis) supplies Clozaril and generics; Mylan and Teva are listed as generic suppliers.
- Registration status in the United Kingdom: Registered and supplied under prescription-only controls and controlled distribution arrangements.
- OTC / Rx classification: Prescription only (Rx) in the UK due to risk of severe neutropenia and other adverse effects.
Legal status and availability in the UK
Clozapine is prescription-only and is dispensed through hospital and community pharmacies that are enrolled in monitoring programmes.
In our online pharmacy, Clozaril is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Clinical effectiveness in the UK
Can clozapine really help when two antipsychotics have failed?
Within NHS practice, clozapine is considered the gold standard for treatment-resistant schizophrenia and is associated with reduced relapse and fewer admissions for many patients.
Side effects such as sedation, sialorrhoea and constipation can affect quality of life.
Adherence can be challenging because of mandatory blood testing, side effects and controlled distribution requirements, so shared-care arrangements are widely used.
Shared care usually involves a consultant psychiatrist overseeing treatment while community pharmacies support dispensing and monitoring.
- Outcome measures: reduced admission frequency; decreased relapse; improved vocational and social functioning.
- Adverse events: early discontinuation can occur because of myocarditis or neutropenia; seizures are dose-related.
- Treatment-resistant definition: failure of at least two adequate trials of antipsychotics at therapeutic doses and durations.
- Treatment-resistant definition: persistent significant positive symptoms or functional impairment despite adequate trials.
Indications and expanded uses
Do I need a special reason to be prescribed clozapine?
Licensed indications in the UK include treatment-resistant schizophrenia, schizophrenia in patients with severe neurological adverse reactions to other antipsychotics, and psychotic disorders in Parkinson's disease.
Off-label uses are limited and typically managed in specialist settings with consultant oversight and documented risk assessment.
Examples of specialist off-label use can include refractory schizoaffective presentations, but these are consultant-led decisions.
All uses require enrolment in a blood-monitoring programme because of agranulocytosis risk.
| Use | Evidence strength | Monitoring requirement |
|---|---|---|
| Treatment-resistant schizophrenia (licensed) | High (NHS guidance and specialist consensus) | Mandatory blood monitoring and controlled distribution; weekly for 18 weeks, then every two weeks until one year, then every four weeks. |
| Psychosis in Parkinson's disease (licensed) | Specialist use only | Consultant-led risk assessment and monitoring enrolment required. |
| Refractory schizoaffective disorder (off-label) | Limited; specialist case reports and clinic experience | Mandatory monitoring; consultant supervision required. |
Composition and brand landscape
Which brands and formats will I see at the pharmacy?
The active ingredient is clozapine (INN), classified under ATC code N05AH02.
Recognised brand names in the UK market include Clozaril, and several generics are available from Mylan, Teva and others.
Dosage forms available include tablets (25 mg, 50 mg, 100 mg, 200 mg), ODTs (12.5 mg, 25 mg, 100 mg) and an oral suspension 50 mg/mL.
| Brand | Supplier | Forms |
|---|---|---|
| Clozaril | Sandoz / Novartis | Tablets (25 mg, 100 mg); packaging varies. |
| Generic clozapine | Mylan, Teva | Tablets, ODTs, oral suspension |
Packaging is supplied as child-resistant bottles or unit-dose blisters to support safety and monitoring compliance.
Contraindications and special precautions
Who should not take clozapine or needs extra care?
- Absolute contraindications: Known hypersensitivity to clozapine or excipients.
- Absolute contraindications: Severe neutropenia or agranulocytosis unless treatable and benefits outweigh risks.
- Absolute contraindications: Uncontrolled epilepsy, severe CNS depression or coma, history of clozapine-induced myocarditis or severe cardiac disease.
- Relative contraindications: Significant hepatic or renal impairment, history of seizures, prostatic hypertrophy, glaucoma, severe constipation or GI obstruction.
- Special populations: Pregnancy and breastfeeding require specialist obstetric psychiatry discussion; use only if benefits clearly outweigh risks.
Monitoring timeline: weekly blood tests for the first 18 weeks, then every two weeks until one year, then every four weeks, with immediate review if neutropenia or myocarditis signs occur.
Daily-living advice: Avoid excess alcohol, take care when driving if sedated, and report severe constipation promptly because it can be serious.
Dosage guidelines
How is clozapine started and adjusted safely?
Initiation normally starts at 12.5 mg once or twice on day one, with slow titration over 2–3 weeks to a typical maintenance dose of 300–450 mg/day in divided doses.
Specialist contexts may use higher doses up to a maximum reported 900 mg/day under close supervision.
- Day 1: 12.5 mg once or twice to begin.
- Days 2–7: Gradual increases guided by tolerability and blood results; slow titration is essential.
- Week 2–3: Aim for maintenance range 300–450 mg/day in divided doses unless contraindicated.
- Adjust further only in specialist settings with plasma monitoring and ECG as needed.
| Population | Dose adjustment guidance |
|---|---|
| Elderly | Start 12.5 mg once daily; titrate very slowly and monitor orthostatic effects. |
| Renal impairment | Lower initial dose and slower titration with frequent monitoring. |
| Hepatic impairment | Lower initial dose; avoid if severe impairment. |
Missed-dose rules: If a dose is missed for less than 48 hours, take it as soon as remembered; if more than 48 hours have passed, restart at the initial low dose and retitrate.
Overdose: Seek emergency medical attention for sedation, respiratory depression or cardiac symptoms.
Interactions overview
What drugs and habits change clozapine levels or risk?
Clozapine is metabolised mainly by CYP1A2, with minor CYP3A4 and CYP2D6 involvement.
Cigarette smoking induces CYP1A2 and lowers plasma clozapine concentrations, so stopping smoking can raise clozapine levels and increase toxicity risk.
| Concomitant drug | Interaction risk |
|---|---|
| Fluvoxamine (CYP1A2 inhibitor) | Can markedly increase clozapine concentrations; dose reduction and monitoring required. |
| Ciprofloxacin | CYP1A2 inhibitor; can increase clozapine levels; monitor closely. |
| Benzodiazepines | Increase sedation and respiratory depression risk when combined with clozapine. |
| Anticholinergic agents | Worsen constipation and urinary retention; use caution. |
- Smoking: Induces CYP1A2 and lowers levels; stopping smoking can increase levels — inform your prescriber.
- Caffeine: High intake can interfere with plasma monitoring and stimulant effects; advise moderation.
- Alcohol: Potentiates sedation and orthostatic hypotension; avoid excess use.
Comparable medicines and prescribing preferences
What are the usual alternatives if clozapine is unsuitable?
NHS clinicians commonly consider other atypical antipsychotics such as olanzapine, risperidone and quetiapine when clozapine is unsuitable or declined.
Those alternatives avoid intensive blood monitoring but are generally considered less effective in established treatment-resistant schizophrenia.
| Drug | Efficacy in TRS | Monitoring needs | Key adverse effects |
|---|---|---|---|
| Olanzapine | Moderate | Routine prescribing monitoring | Weight gain, metabolic risk |
| Risperidone | Moderate | Routine monitoring | Extrapyramidal symptoms, hyperprolactinaemia |
| Quetiapine | Moderate | Routine monitoring | Sedation, metabolic effects |
Clinicians weigh efficacy (clozapine highest for TRS), monitoring burden (clozapine highest), metabolic risk and patient preference when choosing therapy.
Frequently asked questions — common NHS patient questions
How often will I need blood tests?
Answer: Weekly blood tests for the first 18 weeks, then every two weeks until one year, and every four weeks after that, as required by the monitoring programme.
Can I drive while taking clozapine?
Answer: Only if you are not affected by sedation, dizziness or orthostatic hypotension; report symptoms to your clinician and check DVLA guidance.
What if I stop smoking?
Answer: Smoking cessation can raise clozapine levels; inform your prescriber promptly so plasma levels and dose can be reviewed.
Guidelines for proper use
What should a pharmacist tell a patient starting clozapine?
- Confirm the patient is enrolled in the blood-monitoring programme and record next blood-test dates.
- Explain the starting and titration schedule and the missed-dose instructions (if >48 hours restart at low dose and retitrate).
- Counsel on common side effects and practical measures: manage constipation, remedies for sialorrhoea, and sleep hygiene for sedation.
- Advise on interactions with smoking, caffeine and alcohol and on the need to report planned medication changes (including antibiotics).
- Warn about myocarditis red flags such as chest pain, unexplained fever or breathlessness and advise immediate emergency assessment if these occur.
Dispensing requirements: Only pharmacies enrolled in the monitoring scheme may supply clozapine and packaging is often child-resistant or unit-dose to support adherence and safety.
- Urgent red-flag symptoms: acute chest pain, unexplained fever, shortness of breath, sudden onset severe constipation or signs of infection.
- Urgent red-flag symptoms: faecal impaction or severe abdominal pain requiring immediate medical attention.
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Manchester | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | England | 9–21 days |
| Liverpool | England | 9–21 days |
| Sheffield | England | 9–21 days |
| Bristol | England | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Newcastle Upon Tyne | England | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Nottingham | England | 9–21 days |
